This inventor holds 1 USPTO granted patent. Top assignee: Luitpold Pharmaceuticals, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Mark Fisher: Innovator in Anticancer Conjugates
Introduction
Mark Fisher is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of cancer treatment through his innovative work. His research focuses on the development of conjugates that combine fatty acids with anticancer agents.
Latest Patents
Mark Fisher holds a patent for "Fatty acid-anticancer conjugates and uses thereof." This invention provides conjugates of fatty acids and anticancer agents that are useful in treating cancer. The patent also includes compositions and formulations of these conjugates, along with methods for their use.
Career Highlights
Mark Fisher is currently associated with Luitpold Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical innovations. His work has the potential to impact cancer treatment significantly.
Collaborations
Mark has collaborated with notable colleagues, including Nigel L Webb and Matthews O Bradley. These partnerships enhance the research and development efforts in the field of anticancer therapies.
Conclusion
Mark Fisher's contributions to the field of cancer treatment through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to inspire advancements in pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile